4//SEC Filing
Campbell Shannon 4
Accession 0001415889-25-017053
CIK 0001701541other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:24 PM ET
Size
5.7 KB
Accession
0001415889-25-017053
Insider Transaction Report
Form 4
Campbell Shannon
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-12+30,550→ 30,550 totalExercise: $2.43Exp: 2035-06-11→ Common Stock (30,550 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0002018966
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 6:24 PM ET
- Size
- 5.7 KB